UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
International journal of molecular sciences, ISSN 1422-0067, 2012, Volume 13, Issue 1, pp. 828 - 839
Cyclin | Cyclin-dependent kinase inhibitors | Lewis(y) antigen | Cyclin-dependent kinases | Cell cycle | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Cyclin D1 - metabolism | Cyclin-Dependent Kinase 4 - genetics | Humans | Ovarian Neoplasms - pathology | Extracellular Signal-Regulated MAP Kinases - antagonists & inhibitors | Cyclin A - genetics | Extracellular Signal-Regulated MAP Kinases - metabolism | RNA, Messenger - metabolism | Cyclin E - genetics | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Cyclin-Dependent Kinase Inhibitor p21 - genetics | Antibodies - immunology | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Female | Flavonoids - pharmacology | Ovarian Neoplasms - metabolism | Chromones - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Lewis Blood-Group System - immunology | Cyclin-Dependent Kinase 2 - metabolism | Fucosyltransferases - genetics | Cyclin A - metabolism | Cyclin-Dependent Kinase 6 - genetics | Cyclin-Dependent Kinase 2 - genetics | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Morpholines - pharmacology | Cyclin-Dependent Kinase 6 - metabolism | Cyclin-Dependent Kinase 4 - metabolism | Fucosyltransferases - metabolism | Cyclin D1 - genetics | Signal Transduction - drug effects | Cell Line, Tumor | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Lewis Blood-Group System - metabolism | Lewis Blood-Group System - genetics | Cyclin E - metabolism | Cyclin-Dependent Kinase Inhibitor p27 - genetics | Cell proliferation | Galactoside 2- alpha -L-fucosyltransferase | Antibodies | Extracellular signal-regulated kinase | AKT protein | MAP kinase | mRNA | Gene expression | Cyclin-dependent kinase 4 | Western blotting | 1-Phosphatidylinositol 3-kinase | Cyclin-dependent kinase | Polymerase chain reaction | Signal transduction | Transfection | Cyclin A | Cyclin E | cyclin D1 | Index Medicus | cyclin | cyclin-dependent kinases | cyclin-dependent kinase inhibitors | cell cycle
Journal Article
Nature reviews. Cancer, ISSN 1474-175X, 03/2009, Volume 9, Issue 3, pp. 153 - 166
Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplastic Stem Cells - cytology | Cell Proliferation | Mitosis | Humans | Cyclin E - physiology | Neoplasms - drug therapy | Animals | Cell Cycle | Neoplasms - genetics | Protein Kinase Inhibitors - therapeutic use | Chromosome Aberrations | Cyclins - physiology | Cyclin D | Cyclin-Dependent Kinases - antagonists & inhibitors | DNA Damage | Neoplasms - pathology | Chromosomal Instability | Cyclin-Dependent Kinases - physiology | Care and treatment | Cell cycle | Physiological aspects | Genetic aspects | Research | Protein kinases | Cancer | Index Medicus
Journal Article
Cell death & disease, ISSN 2041-4889, 04/2019, Volume 10, Issue 4, pp. 271 - 271
Life Sciences & Biomedicine | Science & Technology | Cell Biology | Cell Division - genetics | Cyclin-Dependent Kinase Inhibitor p18 - deficiency | Transduction, Genetic | Mice, Inbred C57BL | Mice, SCID | Cyclin-Dependent Kinase Inhibitor p18 - metabolism | Cyclin-Dependent Kinase Inhibitor p21 - deficiency | Mice, Knockout | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Animals | Cyclin-Dependent Kinase Inhibitor p18 - genetics | Cyclin-Dependent Kinase Inhibitor p21 - genetics | Chromosome Aberrations | Cyclin-Dependent Kinase 2 - antagonists & inhibitors | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Mice, Inbred NOD | Mice | Cyclin-Dependent Kinase Inhibitor p27 - deficiency | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Cellular Reprogramming - genetics | Genomic Instability - genetics | Cyclin-Dependent Kinase Inhibitor p27 - genetics | Fibroblasts - metabolism | Induced Pluripotent Stem Cells - metabolism | Cyclin-dependent kinases | DNA damage | Stem cell transplantation | Kinases | Cyclin-dependent kinase 4 | Genomic instability | Cyclin-dependent kinase | Cyclin-dependent kinase 2 | Cyclin-dependent kinase inhibitor p21 | Clonal deletion | Efficiency | Stem cells | Cell cycle | Cyclin-dependent kinase inhibitor p27 | Pluripotency | Chromosome aberrations | Index Medicus
Journal Article
British journal of cancer, ISSN 0007-0920, 10/2017, Volume 117, Issue 8, pp. 1154 - 1163
Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclin D1 - drug effects | Immunohistochemistry | Cyclin D1 - metabolism | Up-Regulation | Cyclin-Dependent Kinase Inhibitor p21 - drug effects | Apoptosis - drug effects | Carcinoma, Squamous Cell - metabolism | Humans | cdc25 Phosphatases - drug effects | Head and Neck Neoplasms - metabolism | Cyclin-Dependent Kinase 4 - drug effects | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Squamous Cell Carcinoma of Head and Neck | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | cdc25 Phosphatases - metabolism | In Situ Nick-End Labeling | Cyclin-Dependent Kinase 2 - metabolism | ErbB Receptors - antagonists & inhibitors | ErbB Receptors - metabolism | Signal Transduction | Purines - pharmacology | Cyclin A - metabolism | Down-Regulation | Cyclin-Dependent Kinase 4 - metabolism | Blotting, Western | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Cyclin-Dependent Kinase 2 - drug effects | Cell Proliferation - drug effects | Cyclin A - drug effects | Mice | Molecular Docking Simulation | G1 Phase Cell Cycle Checkpoints - drug effects | In Vitro Techniques | Cyclin-Dependent Kinase Inhibitor p27 - drug effects | Index Medicus | Translational Therapeutics | Erk1 | head and neck cancer | cell proliferation | apoptosis | EGF receptor | Akt | SKLB188
Journal Article
Nature communications, ISSN 2041-1723, 04/2015, Volume 6, Issue 1, pp. 6769 - 6769
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | CDC2 Protein Kinase | Humans | Substrate Specificity | Crystallography, X-Ray | Cyclin A - genetics | Cell Cycle Proteins - chemistry | Protein Kinase Inhibitors - chemistry | Cyclin B - genetics | Peptides - chemical synthesis | Cattle | Cell Cycle Proteins - genetics | Conserved Sequence | Carrier Proteins - chemistry | Cyclin-Dependent Kinases - antagonists & inhibitors | Protein Stability | Cyclin-Dependent Kinases - genetics | Binding, Competitive | Protein Structure, Tertiary | Gene Expression | Cyclin-Dependent Kinases - chemistry | Peptides - chemistry | Protein Structure, Secondary | CDC2-CDC28 Kinases - chemistry | Cyclin-Dependent Kinase 2 - genetics | Models, Molecular | Cyclin-Dependent Kinase 2 - chemistry | Recombinant Fusion Proteins - chemistry | Carrier Proteins - genetics | Animals | Protein Binding | Recombinant Fusion Proteins - genetics | Cyclin B - chemistry | Kinetics | Adenosine Triphosphate - chemistry | CDC2-CDC28 Kinases - genetics | Cyclin A - chemistry | Cyclin-dependent kinase | Cyclin-dependent kinase 2 | Eukaryotes | Cyclin B | Cyclin A | Cell cycle | Dephosphorylation | Thermal stability | Substrates | Nature conservation | Crystal structure | Cancer | Index Medicus
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 12/2019, Volume 366, Issue 6471, p. 1330
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Phosphorylation | Biocatalysis | Allosteric Regulation | Humans | Retinoblastoma Protein - metabolism | Crystallography, X-Ray | Cyclin-Dependent Kinase 4 - metabolism | Piperazines - pharmacology | Cyclin D1 - chemistry | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Cyclin-Dependent Kinase 4 - chemistry | Cyclin-Dependent Kinase Inhibitor p27 - chemistry | Cell Line, Tumor | Protein Conformation | Antineoplastic Agents - pharmacology | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Enzyme Activation | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Cell proliferation | Low concentrations | Clinical trials | Activation | Kinases | Antiestrogens | Cyclin D1 | Inactivation | Cyclin-dependent kinase 4 | Monomers | Proteins | Cell cycle | Inhibition | Cyclin D | Assembly | Adenosine triphosphate | Crystal structure | Tyrosine | Deactivation | Tumor cells | Cyclin-dependent kinases | Retinoblastoma protein | Breast cancer | Trimers | ErbB-2 protein | Substrates | Cyclin-dependent kinase 2 | Organic chemistry | Cyclin-dependent kinase inhibitor p21 | Inhibitors | Adenosine kinase | Cyclin-dependent kinase inhibitor p27 | Tumor suppressor genes | Retinoblastoma | ATP | Binding sites | Structural analysis | Tumors | Index Medicus
Journal Article
Oncogene, ISSN 0950-9232, 02/2018, Volume 37, Issue 6, pp. 821 - 832
Biochemistry & Molecular Biology | Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Neoplasms - metabolism | Cyclin D1 - metabolism | Phosphorylation | Cell Proliferation | Proto-Oncogene Proteins p21(ras) - genetics | Cyclin-Dependent Kinase 4 - genetics | Humans | GTP Phosphohydrolases - antagonists & inhibitors | Rats, Nude | Cyclin D1 - antagonists & inhibitors | Neoplasms - genetics | Biomarkers, Tumor - metabolism | Female | Gene Expression Regulation, Neoplastic - drug effects | Tumor Cells, Cultured |